signal has major roles in cellular processes important in tumorigenesis, including migration, invasion, proliferation, and apoptotic sensitivity. New evidence has revealed that, aside from altered expression and effects on global cytosolic free Ca 2ϩ levels via direct transport of Ca 2ϩ , some Ca 2ϩ pumps and channels are able to contribute to tumorigenesis via mechanisms that are independent of their ability to transport Ca 2ϩ or effect global Ca 2ϩ homeostasis in the cytoplasm. Here, we review some of the most recent studies that present evidence of altered Ca 2ϩ channel or pump expression in tumorigenesis and discuss the importance and complexity of localized Ca 2ϩ signaling in events critical for tumor formation.
ATPases; channels; pumps; local Ca 2ϩ , ORAI THE VERSATILITY and complexity of the Ca 2ϩ signal is widely established, with Ca 2ϩ ions involved, either directly or indirectly, in almost every aspect of cellular processes (5, 49) . Comprising an extensive range of signaling components, including channels, pumps, and exchangers, the Ca 2ϩ signaling system is important in the regulation of processes relevant to tumorigenesis, including cell proliferation and apoptosis (5, 49) . Research has increasingly focused on the identification of Ca 2ϩ transporting proteins, with altered expression in cancer, with several publications reviewing this area (49, 63) . The traditional dogma has been that Ca 2ϩ pumps and channels contribute to tumorigenesis through alterations in global cytosolic free Ca 2ϩ concentration. However, very recent discoveries challenge this traditional emphasis and highlight the importance of localized Ca 2ϩ signals from intracellular compartments and subcellular microdomains. These studies also suggest that some Ca 2ϩ pumps and channels can promote tumor progression via unique mechanisms, which are independent of Ca 2ϩ transporting function. This review aims to provide an insight into the most recent developments and findings relating to aberrant expression of Ca 2ϩ transporters in various cancer types and also address current controversial and unexplored areas in the field.
Ca 2ϩ Pumps and Channels in Cancer: Recent Progress and Issues
Over the past four years, there has been a significant increase in published work reporting on Ca 2ϩ channels and pumps that are associated with cancer. There has also been a significant increase in the types of cancers that are associated with alterations in the expression of specific Ca 2ϩ transporters. A summary of important Ca 2ϩ transport proteins that are reported to have altered expression or activity in some of the most common cancers is shown in Table 1 .
An association between the plasma membrane Ca 2ϩ -ATPase (PMCA), a p-type ATPase responsible for the extrusion of Ca 2ϩ ions from the cytosol into the extracellular domain, and cancer was established in 1997. SV40 transformed human skin and lung fibroblasts were shown to have reduced levels of PMCA protein (65) . Since that time, further work has been published in the area of PMCAs and cancer. An upregulation of the PMCA2 isoform has been shown to occur in some breast cancer cell lines (40) , and PMCA also has a potential role in regulating the proliferation of MCF-7 breast cancer cells (41) . More recently, work by other laboratories has extended the study of PMCA2 expression to human clinical samples and defined a possible role of PMCA in the acquisition of apoptotic resistance (77) . When PMCA2 is overexpressed in T47D breast cancer cells, alterations are seen in the magnitude and recovery of Ca 2ϩ transients by an increased capacity to extrude Ca 2ϩ from the cytoplasm, significantly reducing apoptosis in response to a Ca 2ϩ ionophore (77) . PMCA2 overexpression may thus contribute to cancer progression via the acquisition of an apoptotic resistant phenotype. Further linking PMCA2 and tumor characteristics, VanHouton et al. (77) also found an association between PMCA2 levels and tumor grade, nodal metastases, and poor clinical outcome.
As suggested by the early work of Reisner et al. (65) in SV40 transformed cells, PMCA can also contribute to tumorigenesis via reduced expression. PMCA4 mRNA levels are downregulated as an early event in human colon tumorigenesis (2) . Correspondingly, when HT-29 colon cancer cells are differentiated with either sodium butyrate or by culturing postconfluence, they have an isoform-specific increase in PMCA4 expression (1, 2) . Compromised Ca 2ϩ efflux may provide colon cancer cells with a growth advantage through the promotion of proliferative pathways; this remodeling in PMCA expression does not occur to a degree that would sensitize colon cancer cells to apoptotic stimuli (2) .
Transient receptor potential (TRP) channels are arguably the most comprehensively studied class of Ca 2ϩ signaling proteins in the context of cancer (43, 71) . Recent studies such as those linking TRPM8 and TRPV6 channels with prostate cancer (6, 22) have provided new depth into the potential significance of TRP channel expression in cancer. Although the overexpression of TRPV6 in prostate cancer has been established, current research aims to investigate the mechanisms by which TRPV6 overexpression contributes to prostate carcinogenesis. TRPV6-mediated Ca 2ϩ influx stimulates activation of the Ca 2ϩ -dependent transcription factor nuclear factor of activated T-cells (NFAT) to modulate proliferation and promote resistance to apoptosis in prostate cancer cells (42) . Another channel implicated in prostate cancer development is a member of the melastatin subfamily of TRP channels, TRPM8, which is overexpressed in early-stage prostate cancer (90) . However, as the disease progresses to a metastatic, androgen-independent stage, TRPM8 expression is downregulated (35, 64) . New research has identified a natural agonist for TRPM8 in the prostate. Gkika et al. (28) show that prostate-specific antigen (PSA), a well-known prostate cancer marker, promotes TRPM8 activity via the bradykinin/protein kinase C signaling pathway. Using cell surface biotinylation, they showed that the increased TRPM8 current was due to an increase in functional TRPM8 channels localized to the plasma membrane. Migration assays show that PSA reduces cell motility (28) .
Further research into the molecular mechanisms underlying prostate cancer progression shows that TRPV2 has a role. TRPV2 mRNA levels are approximately 12 times greater in patients with late-stage metastatic prostate cancer compared with samples from localized primary solid tumors, suggesting TRPV2 as a potential prognostic marker for this late-stage of disease (48) . Overexpression appears to bestow elevated cytosolic Ca 2ϩ levels to the cell, which enhances their ability to migrate and invade into adjacent tissue, through direct regulation of key invasion proteases such as the matrix metalloproteinases MMP2 and MMP9 (48) . Interestingly, another recent study reported a progressive decline in TRPV2 levels corresponding to increasing histological grade in human glioma tissue. Small interfering RNA (siRNA) silencing of TRPV2 resulted in increased cell proliferation and resistance to apoptosis via a pathway dependent on extracellular signal-regulated kinase activation (51) . Given the association of TRPV2 with prostate cancer and glioma, further studies of TRPV2 in a variety of cancer models are warranted. Recent work has also extended the association between TRP channels and cancer to other TRP classes and other cancers as exemplified by the marked overexpression of TRPC3 protein in human ovarian cancer samples (89) . TRPC3 knockdown using siRNA leads to a decrease in cell proliferation via the induction of G 2 /M phase cell cycle arrest, suggesting a functional consequence of the channel's overexpression (89) . In support of canonical TRP channels playing an essential role in cell cycle progression, a similar involvement of TRPC6 was recently reported in human glioma cells, where inhibition of TRPC6 activity or expression attenuated intracellular Ca 2ϩ influx, also arresting cells at the G 2 /M phase and suppressing cell growth (13) .
The most rapid acceleration of knowledge in recent years in the field is related to the study of ORAI ion channels in cancer. This is in part due to the identification of STIM proteins and ORAI channels as components of store-operated Ca 2ϩ entry in 2005 and 2006, respectively (45, 66, 80) . Store-operated Ca 2ϩ entry is the predominant manner of Ca 2ϩ influx in nonexcitable cells (79) . The most widely studied proteins of these classes are STIM1, which functions as an endoplasmic reticulum (ER) Ca 2ϩ sensor, and ORAI1, which is an essential component of the channel pore (61, 79) . Studies on the role of store-operated Ca 2ϩ entry in tumor metastasis were limited until Yang et al. (88) provided evidence for the role of STIM1 and ORAI1 in the migration of MDA-MB-231 breast cancer cells. The study was extended into an animal model, using immunodeficient NOD/SCID mice to confirm a reduction of breast tumor metastasis with STIM1 and ORAI1 knockdown (88) .
Subsequent to this work was the finding of McAndrew et al. (47) that ORAI1 levels are significantly elevated (up to 21-fold) in some breast cancer cell lines, relative to normal 184A1 breast cells, and that ORAI1 siRNA-mediated inhibition in MCF-7 and MDA-MB-231 cells attenuates store-operated Ca 2ϩ entry and viable cell number. ORAI1 activity may be augmented in some breast cancers via mechanisms distinct from an increase in ORAI1 expression level. An analysis of microarray data from 295 clinical samples of breast cancers showed that tumors defined transcriptionally as basal-like were characterized by high STIM1 and low STIM2 mRNA expression (47) . This increase in STIM1 relative to STIM2 was associated with a poorer patient prognosis (47) . This study also showed that STIM1 siRNA-mediated inhibition had more pronounced effects on store-operated Ca 2ϩ entry than inhibition of STIM2 (47) . This work suggests that basal breast cancer cells may have augmented store-operated Ca 2ϩ entry. The association between store-operated Ca 2ϩ entry and cancer is now being extended to the less well-studied ORAI channels such as ORAI3. Faouzi et al. (19) report that ORAI3 mRNA is overexpressed in the estrogen receptor-positive breast cancer cell lines MCF-7 and T47D compared with the nontumorigenic MCF-10A breast cell line. ORAI3 mRNA is also increased in some human breast tumors compared with normal breast samples (19) . Downregulation of ORAI3 inhibits cancer cell proliferation, contributes to cell cycle arrest at the G 1 phase, and increases apoptotic cell death (19) . ORAI3 silencing in the nontumorigenic MCF-10A cells did not change proliferation (19) , suggesting that the ORAI3 signaling pathway is a potential therapeutic target in some human breast cancers. Work by Motiani et al. (50) has linked ORAI3 to the store-operated Ca 2ϩ entry pathway used in estrogen receptorpositive breast cancer cells and report elevated ORAI3 protein in some estrogen receptor-positive cell lines. Collectively, these results highlight an interesting and diverse role for the store-operated Ca 2ϩ pathway components in breast tumorigenesis and attest to the value of further research in this area.
There are limited studies on the role of the principal components of store-operated Ca 2ϩ entry in cancers originating from areas outside of the breast. However, interest in other cancer types is an emerging area as reflected in recent work linking ORAI1 to prostate cancer (23) . ORAI1 is downregulated during the transition to an androgen-independent phenotype in prostate cancer cells. ORAI1 inhibition in LNCaP cells results in resistance to apoptosis mediated by the sarco-endoplasmic reticulum Ca 2ϩ -ATPase inhibitor thapsigargin (23) . Furthermore, downregulation of ORAI1 in LNCaP cells protects the cells from chemotherapy-induced apoptosis, using cisplatin and oxaliplatin, two clinically used agents (23) . Hence, advanced prostate cancers may acquire resistance to treatment in part due to ORAI1 downregulation. These results reflect the importance of the ORAI/STIM proteins and the store-operated Ca 2ϩ signaling pathway in the pathogenesis of cancers and will provoke further research in this field.
Ca 2ϩ Transporters and Tumorigenesis: New Mechanisms and New Complexities
The majority of studies in the context of Ca 2ϩ transport in cancer have of course focused on exploring the relationship between how alterations in the expression of a Ca 2ϩ channel or pump mediate their effects via the direct movement of Ca 2ϩ ions through the pore of the channel or pump. However, recent studies in cell lines of both tumorigenic and nontumorigenic origin offer alternative mechanisms. Tumorigenic processes, in some cases, may be promoted via unique mechanisms that are independent of the Ca 2ϩ transporting function of the protein or effects on global cytosolic free Ca 2ϩ . The contribution of the secretory pathway Ca 2ϩ ATPases (SPCAs) in the context of cancer was largely unexplored until recent work by Feng et al. (20) on SPCA2. SPCA2 is a Golgi-localized p-type Ca 2ϩ -ATPase first characterized in 2005 (78, 86) . SPCA2 mRNA levels are upregulated in luminal-like breast cancer cell lines (20) . The consequence of SPCA2 upregulation is an increase in cell proliferation and tumorigenicity (as assessed by growth on soft agar). Detailed examination into the mechanisms responsible for the effect revealed the ability of SPCA2 to localize to the plasma membrane and elicit constitutive Ca 2ϩ influx through direct interaction of its NH 2 -terminus with ORAI1 (20) . The separation of the ORAI1 activation function from the ion transporting ability of SPCA2 was demonstrated by the ability of ion transportdeficient mutants to activate Ca 2ϩ influx, NFAT signaling, and proliferation. This study provides an example of how a Ca 2ϩ pump can augment cancer processes via a mechanism distinct Themes C971 Ca 2ϩ TRANSPORT IN CANCER from its primary Ca 2ϩ transport function. Physiologically, such a mechanism may be important in processes requiring sustained Ca 2ϩ secretion such as lactation, where SPCA2 expression is increased (18) .
The complexity of ORAI channel regulation is further highlighted by the ability of STIM2 to activate ORAI1 in a store-independent manner (30) . STIM2 has now been reported to exist in distinct functional forms: the widely investigated STIM2 and another population, referred to as pre-STIM2, that is able to escape ER targeting (30) . Immunolocalization revealed that cytosolic pre-STIM2 localizes to the plasma membrane, where it interacts with ORAI1, increasing basal Ca 2ϩ concentration in a manner that is independent of ER Ca 2ϩ store depletion (30) . The increase in basal Ca 2ϩ concentration by pre-STIM2 results in the induction of NFAT and nuclear factor-B (NF-B)-mediated gene transcription (30) . Further to this, a third population, which is actually a fragment of the STIM2 signal peptide, upon its release from the ER membrane into the cytoplasm, becomes a regulator of gene transcription in a Ca 2ϩ independent fashion (30) . Together, these findings support the repositioning of paralogs in protein families into subcellular compartments as an emerging method for the functional diversification of replicated genes (30) . Given the role of SPCA2 regulation of ORAI1 in breast cancer, assessment of pre-STIM2 in cancers, including those aside from the breast would now seem a priority. Figure 1 is a schematic representation that summarizes regulators of ORAI1 channels and activation associated with tumorigenesis as described in this review.
SPCA2, which as discussed above, activates ORAI1, is not the only example of a Ca 2ϩ transporter with dual functionality. In neuronal cells, the voltage-gated channel Ca V 1.2 can produce a COOH-terminal fragment of Ca V 1.2 known as Ca 2ϩ channel-associated transcriptional regulator (CCAT) (29) . CCAT translocates into the nucleus, binds to nuclear proteins such as p54(nrb)/NonO, and regulates the expression of genes critical for neuronal signaling (29) . The potential significance of such mechanisms in cancer is still to be explored.
Another recent study by Wang et al. (83) provides further insight into mechanisms by which Ca 2ϩ channels may be regulated, suggesting a crucial link between receptor-induced Ca 2ϩ store depletion and the control of voltage-activated signals. This group showed that STIM1 activation by store depletion not only leads to the activation of ORAI channels but also attenuates the activity of Ca V 1.2 (83) . Although the action of STIM1 on Ca V 1.2 is independent of ORAI channels, its effects on both of these Ca 2ϩ channels are spatially and functionally connected. ORAI channels trap STIM1 in puncta and cause STIM1 to become closely associated with Ca V 1.2 channels (83). One could postulate that cancer cells could have deregulation of these complex channel regulation mechanisms.
The arachidonic acid pathway has been implicated as a key inflammatory pathway involved in the cellular signaling contributing to prostate carcinogenesis (56, 76) . Arachidonic acid is an inhibitor of TRPM8, a channel overexpressed in androgen-dependent prostate cancer (75, 90) . However, the physiological pathways and surface receptors mediating the effect of arachidonic acid on cancer progression remain largely uninvestigated. Bavencoffe et al. (4) have recently reported on the role of arachidonic acid release in the complex regulation of TRPM8 through the M3-type muscarinic acetylecholine receptor-coupled signaling cascade. Their results showed that the application of a nonselective muscarinic agonist suppressed the activity of TRPM8 channels expressed in HEK-293 cells via stimulation of cytosolic phospholipase A2 (cPLA2) and subsequent generation of arachidonic acid. Further research into other surface receptors as regulators of ion channel activity in cancer cells is now required.
Localized Ca 2ϩ Signaling
Changes in global cytosolic Ca 2ϩ homeostasis through alterations in Ca 2ϩ transporter expression or activity has been the focus of researchers characterizing changes in Ca 2ϩ signaling in cancer cells (49) . Spatially restricted Ca 2ϩ signaling within specific cellular compartments or discrete cytosolic domains provides an additional layer of complexity in the regulation of cellular processes important in tumorigenesis; however, this has not yet been extensively assessed in the context of cancer.
Compartmental Ca 2ϩ
Ca 2ϩ gradients, such as those maintained by the ER, mitochondria, nucleus, and the Golgi help confer versatility to the Ca 2ϩ signal, enabling the control of many cellular processes within a single cell (5) . An example of the deregulation of Ca 2ϩ stores that may occur in cancer is seen in the regulation of ER Ca 2ϩ homeostasis by the anti-apoptotic protein BCL2. Ca 2ϩ transfer from the ER to the mitochondria, if sufficient in magnitude, leads to the activation of cell death pathways (59) . Many studies have now established a role for BCL2 in the inhibition of Ca 2ϩ transfer between these often closely apposed organelles (9, 33, 59) . A reduction in the luminal ER free Ca (26) . The notion of a nuclear-cytoplasmic Ca 2ϩ gradient has obvious implications for the regulation of gene transcription during tumorigenesis. One possible mechanism for a differential Ca 2ϩ concentration between the cytosol and the nucleus may be buffering of Ca 2ϩ by perinuclear mitochondria (26) . Careful studies in cancer cells are required before the potential impact of this phenomenon on aberrant gene transcription in cancer cells and tumor progression can be fully understood.
Posttranslational protein modification and the trafficking of secreted proteins is the responsibility of the Golgi, which maintains a relatively high luminal Ca 2ϩ concentration compared with the cytosol (60) . This Ca 2ϩ gradient appears to be predominately mediated via SPCAs. Recent studies assessing the potential significance of SPCA1 upregulation in the basal breast cancer subtype has shown that the silencing of SPCA1 inhibits the processing of the insulin-like growth factor receptor-1 (31). This change occurs without an impact on general cytosolic free Ca 2ϩ homeostasis (e.g., changes in [Ca 2ϩ ] CYT recovery after stimulation). Hence, some Ca 2ϩ transporters may contribute to tumor progression through alterations in Golgi luminal Ca 2ϩ . Rather than altering cytosolic Ca 2ϩ dynamics, SPCA1 may contribute to cancer pathways by altering the activity of Ca 2ϩ -regulated enzymes that are responsible for the posttranslational modification of proteins important in cell proliferation, apoptosis, and differentiation (31) .
Spatial Heterogeneity in Cytosolic Ca 2ϩ Signaling
The importance of localized Ca 2ϩ signaling during excitation-transcription coupling is increasingly investigated in neurons and during the phenotypic conversion of vascular smooth muscle cells (46, 81 (67, 68) and the ability of localized Ca 2ϩ signaling to regulate these proteins highlights the need for this aspect of their regulation to be further explored in tumorigenesis. Localized Ca 2ϩ events, defined as Ca 2ϩ "flickers," are also an important regulator of migration in human embryonic lung fibroblasts exposed to a growth-factor gradient (84) and are another example of a pathway that requires further assessment in cancer cells.
Regulation of gene transcription via NFAT is a defining feature of local store-operated Ca 2ϩ entry currents (21) , which as discussed previously in this review, is a Ca 2ϩ influx pathway increasingly linked to cancer. The NFAT family of transcription factors regulates many cancer-related processes including cellular differentiation, migration, and angiogenesis. Kar et al. (36) The link between Ca 2ϩ transporters and cancer may be through specific plasma membrane domains such as plasmalemmal lipid rafts and caveolae (54) . Caveolae are membranous invaginations that serve as signaling complexes via the clustering of related signaling proteins into discrete microdomains (55) . Upon ER Ca 2ϩ store depletion, the fraction of the Ca 2ϩ channel TRPC1 and the ORAI1 channel activator STIM1 localized to the lipid raft domain increases (53) . Several studies have demonstrated an interaction between ORAI1 and caveolin-1 (54), and when combined with studies showing that pharmacological disruption of lipid rafts impairs store-operated Ca 2ϩ entry (53), provide compelling evidence for the importance of plasma membrane microdomains in this type of Ca 2ϩ influx. This relationship has significant implications in cancer, as the caveolae coat protein caveolin-1 is linked to processes important in cancer metastasis (87) and is enriched in clinical breast cancer samples associated with a poor prognosis (16) .
One important implication of localized Ca 2ϩ signaling may be a divergence between studies investigating the expression of Ca 2ϩ transporters in cancer and those assessing function. Proteins with a relatively low endogenous expression may still wield significant responses in cells due to regions of privileged Ca 2ϩ signaling in the vicinity of downstream targets, and thus should not be disregarded as having a role in tumorigenesis (Fig. 2) . Conversely, models founded on heterologous expression of proteins that signal via localized Ca 2ϩ may be misleading. Forced expression of these proteins may skew the ratio between the protein of interest and its natural downstream signaling partners. Although these studies may provide valuable information for research, they should not be interpreted in isolation, rather in conjunction with studies assessing the functional role of these proteins in physiology and pathophysiology.
Conclusion
In summary, this review has focused on very recent discoveries of changes in the expression and/or activity of important Ca 2ϩ transporters in cancer cells, such as the overexpression of TRPC3 in ovarian cancer and ORAI-mediated Ca 2ϩ influx in some breast cancer cells. We have also described unusual mechanisms by which some Ca 2ϩ transporters contribute to tumorigenesis in a manner distinct from their primary transporting function or global cytosolic Ca 2ϩ levels. Over the next five years, we will see current advanced approaches to the study of Ca 2ϩ signaling being used to define the mechanisms by which Ca 2ϩ transporters contribute to tumorigenesis.
